Literature DB >> 32938773

Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China.

Jiali Song1, Karthik Murugiah2,3, Shuang Hu1, Yan Gao1, Xi Li1, Harlan M Krumholz2,3,4, Xin Zheng5.   

Abstract

BACKGROUND: Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction (AMI) after initial AMI remain poorly understood. Data on recurrent AMI in China is unknown.
METHODS: Using the China Patient-centred Evaluative Assessment of Cardiac Events (PEACE)-Prospective AMI Study, we studied 3387 patients admitted to 53 hospitals for AMI and discharged alive. The association of recurrent AMI with 1-year mortality was evaluated using time-dependent Cox regression. Recurrent AMI events were classified as early (1-30 days), late (31-180 days), and very late (181-365 days). Their impacts on 1-year mortality were estimated by Kaplan-Meier methodology and compared by the log-rank test. Multivariable modelling was used to identify factors associated with recurrent AMI.
RESULTS: The mean (SD) age was 60.7 (11.9) years and 783 (23.1%) were women. The observed 1-year recurrent AMI rate was 2.5% (95% CI 2.00 to 3.07) with 35.7% events occurring within the first 30 days. Recurrent AMI was associated with 1-year mortality with an adjusted HR of 25.42 (95% CI 15.27 to 42.34). Early recurrent AMI was associated with the highest 1-year mortality rate of 53.3% (log-rank p<0.001). Predictors of recurrent AMI included age 75-84, in-hospital percutaneous coronary intervention, heart rate >90 min/beats at initial admission, renal dysfunction, and not being prescribed any of guideline-based medications at discharge.
CONCLUSIONS: One-third of recurrent AMI events occurred early. Recurrent AMI is strongly associated with 1-year mortality, particularly if early. Heightened surveillance during this early period and improving prescription of recommended discharge medications may reduce recurrent AMI in China. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute myocardial infarction; quality and outcomes of care

Year:  2020        PMID: 32938773     DOI: 10.1136/heartjnl-2020-317165

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  9 in total

Review 1.  New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease.

Authors:  Achim Leo Burger; Edita Pogran; Marie Muthspiel; Christoph Clemens Kaufmann; Bernhard Jäger; Kurt Huber
Journal:  Biomedicines       Date:  2022-04-22

2.  Incidence, Characteristics, and Management of Patients with Recurrent Myocardial Infarctions: Insights from the EYESHOT POST-MI.

Authors:  Leonardo De Luca; Furio Colivicchi; Domenico Gabrielli; Donata Lucci; Gabriele Grippo; Francesco Piemonte; Bruno Villari; Andrea Di Lenarda; Fabrizio Oliva; Michele Massimo Gulizia
Journal:  J Interv Cardiol       Date:  2022-03-18       Impact factor: 2.279

3.  Development and validation of a novel risk score to predict 5-year mortality in patients with acute myocardial infarction in China: a retrospective study.

Authors:  Yan Tang; Yuanyuan Bai; Yuanyuan Chen; Xuejing Sun; Yunmin Shi; Tian He; Mengqing Jiang; Yujie Wang; Mingxing Wu; Zhiliu Peng; Suzhen Liu; Weihong Jiang; Yao Lu; Hong Yuan; Jingjing Cai
Journal:  PeerJ       Date:  2022-01-04       Impact factor: 2.984

4.  Plasma Quantitative Lipid Profiles: Identification of CarnitineC18:1-OH, CarnitineC18:2-OH and FFA (20:1) as Novel Biomarkers for Pre-warning and Prognosis in Acute Myocardial Infarction.

Authors:  Jun Liu; Liangqiu Tang; Qiqi Lu; Yi Yu; Qiu-Gui Xu; Shanqiang Zhang; Yun-Xian Chen; Wen-Jie Dai; Ji-Cheng Li
Journal:  Front Cardiovasc Med       Date:  2022-04-11

5.  Consistency analysis of high-sensitivity cardiac troponin I in peripheral blood and venous blood by quantum dot immunofluorescence assay and clinical application in acute myocardial infarction.

Authors:  Haohao Liu; Fang Luo; Lizhu Zhang; Zhijun Han; Mingxiang Shao; Hong Du
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

6.  Predictors of recurrent acute myocardial infarction despite successful percutaneous coronary intervention.

Authors:  Sang Hun Lee; Myung Ho Jeong; Joon Ho Ahn; Dae Young Hyun; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Jin Yong Hwang; Weon Kim; Jong Seon Park; Chang-Hwan Yoon; Seung Ho Hur; Sang Rok Lee; Kwang Soo Cha
Journal:  Korean J Intern Med       Date:  2022-06-28       Impact factor: 3.165

Review 7.  Cytokine storm: behind the scenes of the collateral circulation after acute myocardial infarction.

Authors:  Weixin He; Peixian Chen; Qingquan Chen; Zongtong Cai; Peidong Zhang
Journal:  Inflamm Res       Date:  2022-07-25       Impact factor: 6.986

8.  When More Means Less: The Prognosis of Recurrent Acute Myocardial Infarctions.

Authors:  Ygal Plakht; Harel Gilutz; Arthur Shiyovich
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

9.  Reduction in GLP-1 secretory capacity may be a novel independent risk factor of coronary artery stenosis.

Authors:  Chihiro Nagase; Masaya Tanno; Hidemichi Kouzu; Takayuki Miki; Junichi Nishida; Naoto Murakami; Nobuaki Kokubu; Nobutaka Nagano; Ryo Nishikawa; Nobuhiro Yoshioka; Tohru Hasegawa; Hiroyuki Kita; Akihito Tsuchida; Hirofumi Ohnishi; Tetsuji Miura
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.